Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2014-06-15 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-OUEN-SUR-SEINE (93400), Seine-Saint-Denis
PHARMACIE HALOUA AVAKIANTZ : revenue, balance sheet and financial ratios
PHARMACIE HALOUA AVAKIANTZ is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-OUEN-SUR-SEINE (93400),
this company of category PME
shows in 2018 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE HALOUA AVAKIANTZ (SIREN 802341735)
Indicator
2022
2018
2017
2016
2015
Revenue
N/C
1 887 131 €
1 844 897 €
1 889 923 €
1 388 747 €
Net income
284 612 €
154 896 €
141 543 €
135 292 €
52 869 €
EBITDA
N/C
224 283 €
208 132 €
205 727 €
165 182 €
Net margin
N/C
8.2%
7.7%
7.2%
3.8%
Revenue and income statement
In 2022, PHARMACIE HALOUA AVAKIANTZ generates positive net income of 285 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2022: 53 k€ -> 285 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
284 612 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.956%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.202%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2022
Debt ratio
1061.303
438.699
242.878
159.012
40.956
Financial autonomy
7.174
15.681
25.617
34.351
64.202
Repayment capacity
23.008
8.121
6.846
5.565
None
Cash flow / Revenue
3.741%
7.093%
7.495%
8.216%
None%
Sector positioning
Debt ratio
40.962022
2017
2018
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Good-35 pts over 3 years
In 2022, the debt ratio of PHARMACIE HALOUA AVAKIANTZ (40.96) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.2%2022
2017
2018
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Good+38 pts over 3 years
In 2022, the financial autonomy of PHARMACIE HALOUA AVAKIANTZ (64.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
5.57 years2018
2017
2018
Q1: 1.85 years
Med: 5.41 years
Q3: 9.79 years
Average
In 2018, the repayment capacity of PHARMACIE HALOUA AVAKIANTZ (5.57) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 480.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2022
Liquidity ratio
173.907
183.383
221.084
273.49
480.601
Interest coverage
9.592
7.797
6.33
3.813
None
Sector positioning
Liquidity ratio
480.62022
2017
2018
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Excellent
In 2022, the liquidity ratio of PHARMACIE HALOUA AVAKIANTZ (480.60) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.81x2018
2017
2018
Q1: 1.93x
Med: 6.3x
Q3: 12.7x
Average-6 pts over 2 years
In 2018, the interest coverage of PHARMACIE HALOUA AVAKIANTZ (3.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 97 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 492 days. Excellent situation: suppliers finance 395 days of the operating cycle (retail model).
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
97 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
492 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE HALOUA AVAKIANTZ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2022
Operating WCR
138 097 €
128 949 €
171 520 €
144 611 €
0 €
Inventory turnover (days)
33
23
24
22
0
Customer payment term (days)
9
6
4
7
97
Supplier payment term (days)
67
43
39
38
492
Positioning of PHARMACIE HALOUA AVAKIANTZ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE HALOUA AVAKIANTZ is estimated at
3 348 889 €
(range 2 251 119€ - 5 022 712€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
2251k€3348k€5022k€
3 348 889 €Range: 2 251 119€ - 5 022 712€
NAF 5 année 2022
Valuation method used
Net Income Multiple
284 612 €
×
11.8x
=3 348 890 €
Range: 2 251 119€ - 5 022 712€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE HALOUA AVAKIANTZ with other companies in the same sector:
Frequently asked questions about PHARMACIE HALOUA AVAKIANTZ
What is the revenue of PHARMACIE HALOUA AVAKIANTZ ?
The revenue of PHARMACIE HALOUA AVAKIANTZ in 2018 is 1.9 M€.
Is PHARMACIE HALOUA AVAKIANTZ profitable?
Yes, PHARMACIE HALOUA AVAKIANTZ generated a net profit of 285 k€ in 2022.
Where is the headquarters of PHARMACIE HALOUA AVAKIANTZ ?
The headquarters of PHARMACIE HALOUA AVAKIANTZ is located in SAINT-OUEN-SUR-SEINE (93400), in the department Seine-Saint-Denis.
Where to find the tax return of PHARMACIE HALOUA AVAKIANTZ ?
The tax return of PHARMACIE HALOUA AVAKIANTZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE HALOUA AVAKIANTZ operate?
PHARMACIE HALOUA AVAKIANTZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart